FBInvestor
Stocks / Emergent Biosolutions Inc
Institutional Ownership

Emergent Biosolutions Inc

CUSIP 29089Q105COMEBSQ1 2026

13D / 13G Filings
35
Schedule 13D/13G on record
Beneficial Filers
10
Distinct reporting persons
Largest Stake
18.1%
Max % of class reported
Institutional Holders
184
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

35 filings · latest Feb 9, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 9, 2026State Street Corporation13G5.1%2.70MSEC
2Jan 30, 2026The Vanguard Group13G/A6.8%3.55MSEC
3Jul 17, 2025Blackrock, Inc.13G7.3%3.98MSEC
4Nov 13, 2024Oak Hill Advisors LP13G6.4%3.61MSEC
5Nov 8, 2024Charles Schwab Investment Management Inc13G/A4.2%2.22MSEC
6Sep 10, 2024Blackrock Inc.13G/A3.7%1.97MSEC
7Jul 8, 2024Blackrock Inc.13G/A7.3%3.84MSEC
8Jun 7, 2024Blackrock Inc.13G/A12.7%6.64MSEC
9Feb 13, 2024Vanguard Group Inc13G/A5.7%2.97MSEC
10Feb 9, 2024Charles Schwab Investment Management Inc13G5.5%2.87MSEC

25 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Emergent Biosolutions Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →